Golden Horseshoe Biosciences Network - Annual Report

8/14/2019 Golden Horseshoe Biosciences Network - Annual Report

1/16

G o l d e n H o r s e s H o e b i o s c i e n c e s n e t w o r k

w w w . .

t u r n i n G i n n o v a t i o n i n t o e c o n o m i c G r o w t H

GHBN Annual Report 2006-2007


2/16



3/16

w w w . .

Welcome to the inaugural annual report o the Golden Horseshoe Biosciences Network (GHBN).

Networks are all about new partnerships bringing people and organizations together to

create opportunities and solve problems, especially when it comes to large scale change.

Thats something we really believe in and are passionate about in the same way that were

passionate about the economic potential o the Golden Horseshoe.

The Golden Horseshoe has so mch to offer!

With ormidable strengths in manuacturing, engineering, medicine and innovative health

technologies, the Golden Horseshoe has incredible potential or growth. The commercialization

opportunities o bioscience link these strengths together, defning a dynamic and globally

unique uture economy or the region. The GHBNs role as a network is to bring regional

stakeholders together to ully realize this vision, and the approach has been to apply a highly

entrepreneurial model to the eort. In our frst three years, were proud o the extensive working

partnerships weve established with the municipal governments, hospitals, universities, researchinstitutions and industry o Hamilton, Halton and Niagara, resulting in a powerul shared vision

across the region. With more companies leveraging our services each year, more partners joining

the network, and more business support inrastructure being solidifed, our clients are able to

access the programs and services they need to grow.

Were an entreprenerial company thats dedicated to entrepreners

As a network, we open doors to knowledge and fnancial resources. We understand and communicate

government programs and related opportunities or growth. We replace inormation silos with

inormed communication. We understand the needs o our clients at all stages o development.

Through one-on-one consulting and acilitating access to additional programs and services,

we take an active role in client progress toward commercialization and thats an exciting road!

Thank you to the team, the Board o Directors and our partner networks or playing such a

valuable role in the GHBNs success. As we go orward, we will maintain the momentum by

continuing to ocus on the needs o our clients; and along with our partners we will enjoy

listening to the buzz o entrepreneurial activity that will defne the Golden Horseshoes

knowledge-based economy o tomorrow.

Dr. Darlene Homonko, Executive Director

Golden Horseshoe Biosciences Network (GHBN)

C o n t e n t sWho we are .............................

What we do .............................

Formula for success .................

Eye on the future .....................

About us .................................

C o n t a C tFor inormation please contact:

Ana Paredes,

Oce Administrator/

Incubator Assistant GHBN

Email: [email protected]

Tel: (905) 525-9140 ext. 26602

Fax: (905) 528-3999

www.ghbn.org

Dr. Darlene Homonko

Executive Director, GHBN


4/16

who we areThe Glden Hrseshe Bisciences Netwrk (GHBN) is a regional network

o research organizations, companies, universities, and economic developers

involved in biosciences, biotechnology and related elds. Through relationship-

building and entrepreneurial support, the aim is to spur innovation, orm new

ties and develop new research and investment to ensure a thriving innovation

centre in the Golden Horseshoe.

Hw we started

The GHBNs history dates back to 2002, when the Province o Ontario

announced a biotechnology strategy to attract growth and investment, and

ultimately make Ontario one o the most competitive jurisdictions in North

America or biotechnology. The GHBN was incorporated in 2005 to execute the

strategy in the Golden Horseshoe, with a mandate to identiy the commercial

potential o initiatives within hospitals, universities and research institutions;

develop an entrepreneurial culture; create opportunities or start-ups; and put

the supports in place to help small businesses grow. This was a signicant

undertaking, with unctional connections among stakeholder groups virtually

non-existent, and success ultimately requiring undamental shits in mindsets,working relationships and unding models.

A longstanding advocate o the power o networks to eect change, the

approach adopted by Executive Director Dr. Darlene Homonko centered on

acilitating inormed partnerships across the public/private sector interace. A

concerted ocus on complementarities and resource sharing initiated awareness

across traditional silos in government, industry, academia, research institutes and

other ourth pillar organizations, moving toward a connected entrepreneurial

support inrastructure across the region.

the power of network


5/16

Early milestones

Three years int the mandate, the GHBN has:

nEstablished a powerul regional, provincial and international network in support o

a growing culture o innovation in the Golden Horseshoe

nDemystied access to

- Provincial programs that are part o the Ontario Commercialization Strategy

including Ontario Centres o Excellence (OCE), Ontario Commercialization

Investment Funds (OCIF), Next Generation o Jobs Fund, and the Business

Mentorship and Entrepreneurship Program (BMEP)

- Federal programs including the Scientic Research and Experimental

Development (SR&ED) tax credits, Industrial Research Assistance Program (IRAP),and Sustainable Development Technology Canada (SDTC)

nDemonstrated an accelerated commercialization capacity in the Golden Horseshoe,

by helping more than 30 bioscience start-ups and small businesses to grow, through

one-on-one business consulting and linkages to knowledge and fnancial resources

nEmbraced the challenge o sector diversity ranging rom traditional biotechnology

to manuacturing, automotive, horticulture, agri-ood and wine, e-health and

emergent medical devices, clinical trials and bioenergy by acilitating broader

program development and execution through partners

nSet the stage or new commercialization opportunities or entrepreneurs and

researchers, through delivery o a business plan or an 80,000 sq t business

incubator/accelerator centre in association with McMaster University

and McMaster Innovation Park

But perhaps the greatest demonstration o success to date is that the GHBN has

created an audible buzz in the region, with an increasing number o bioscience

entrepreneurs and companies knocking at the door or help in growing their

businesses. Over the next three years, the goal is to maintain momentum and

help more companies evolve and grow. Extensive networking will be central to

the exercise, as the GHBN transitions rom a small but determined group toward

regional icon or eective bioscience business development in the Golden Horseshoe.

In three years o

operation, the GHBN

has replaced almost no

connection between industry

government and academia in

the Golden Horseshoe with a

connected environment that

cultivates entrepreneurship

and commercialization.

An enormous amount o

networking has been central

to this accomplishment, as

people have come together

and created a buzz about the

current activity and potential

o the region. While there

is still much work to do

to create a true innovation

culture here, through the

GHBN weve created an

inormation resource that all

sectors can beneft rom.

Lauren Cuddy

Executive Vice President, i3 Innovus,and Chair o the Board o Directors,Golden Horseshoe Biosciences Network(GHBN)

o effect change


6/16

whatwe do

With extensive experience in bioscience commercialization, a strong commitment toclient needs, a results-oriented attitude and no individual stake in particular innovations

or companies, the GHBN provides a uniquely expedient and non-political route to

bioscience commercialization, with programs and services centered on:

nNetworking and events, to create linkages within and outside the region

nCommunicating government programs

nFacilitating business support inrastructure

nCreating new business opportunities

nHelping companies grow, through mentoring and resource identication

nMeeting entrepreneurial needs, at all stages o growth

Networking & eventsWork at the GHBN is approached as a ull-contact activity with considerable time spent

meeting with entrepreneurs, researchers, partners and government representatives, as well

as attending and hosting related events. Through these eorts, the GHBN is able to:

nMaintain strong relations with partners in economic development and the universities

through proactive communication about individual companies

nWork with decision makers at all levels o government to be well-inormed about

programs and opportunities, and well-poised to help clients gain access

nParticipate in a broad spectrum o partner events and initiatives across Ontario, the

Northeastern U.S. and Europe, to urther enhance the realm o resources or clients

The GHBNs own roster o events is also central to the overall networking eort, with

more than 20 events hosted annually and increasing participants, requests to partner,

and requests to assist other Regional Innovation Networks (RINs) in establishing similar

programs or their clients. Key successes to date include:

nInnatin Ca, the GHBNs fagship discussion series targeted at entrepreneurs,

with central themes o innovation, entrepreneurship and leadership

nPeer t Peer, ocused learning and networking opportunities or senior business leaders

entrepreneurs and small businesses, including the highly successul Seeding Medical

Technology Partnerships Cross-Border Conerence in partnership with York Biotech,

The Health Technology Exchange (HTX), Trillium Medical Technology Association (TMTA),

Bualo Niagara Partnership, MedTech and the Canadian Trade Commissioner ServicenResearch t Receptr Frms, hal-day conerences bringing researchers and

companies together in various cities to advance the discussion o unctional ood and

agriculture research and innovation, conducted in partnership with MaRS Landing and

C4 Consortium

Each o these events/series has gained momentum in the

last three years, with growing numbers o participants and

requests to partner, as well as requests to assist other RINs

in establishing similar programs or their clients.

With universities

traditionally not promoting

their scientifc strengths in

industry circles, its been

very difcult to fnd out

about current research

programs. The greatest

value oering o the GHBN

is acilitating that industry-

university connection.

Steve Boyajian

Business Development Manager,Activation Labs


7/16

Through the GHBN events

I have a much improved

understanding o the

challenges and opportunities

that companies ace, and

where there are opportunities

or my organization to identiy

potential solutions. The more

I know, the more Im able to

serve their interests.

Yvonne Gruenthaler

Trade Commissioner Lie Sciences,Science and Innovation, Regional Oceo the Trade Commissioner Service,Ontario Region, Foreign Aairs andInternational Trade Canada

Going orward, the GHBN also intends to broaden the scope o learning and networking opportunity

or entrepreneurs through more event-based collaboration. Partner organizations will include:

nBioEnterprise, an agency established to help promote the creation, growth and expansion

o businesses in the Agri-Food and Agri-Lie Sciences and Bio-Product IndustriesnRegional and national angel investment networks

nInnovation Synergy Centre Markham (ISCM)

nIndustry associations ocused on materials and manuacturing,

such as the Institute o Electrical Engineers (IEE)

nRegional networks with demonstrated success in strengthening various innovation

sectors relevant to innovation and the Golden Horseshoe, such as the Business

Inormation Technology Network (BitNet)

Communicating government programs

As a Regional Innovation Network (RIN), the GHBN is uniquely positioned to communicate

government programs in both directions to entrepreneurs and small companies that need them,and back to government where direct insight about what companies need helps to inorm program

improvements. Among bioscience companies, theres limited knowledge o government programs

designed to help them grow. The GHBN plays a key role in creating awareness o programs including:

nScientic Research and Experimental Development (SR&ED) tax credits

nIndustrial Research Assistance Program (IRAP), through which the GHBN

also administers $50K year or mentorship programs

nSustainable Development Technology Canada (SDTC)

nOntario Commercialization Strategy Programs, including:

- Ontario Centres o Excellence (OCE)

- Ontario Commercialization Investment Funds (OCIF)

- Next Generation o Jobs Fund- Business Mentorship and Entrepreneurship Program (BMEP)

Following awareness, the GHBN provides hands-on assistance with program application processes,

as well as one-on-one business development consulting. The GHBNs goal is to ensure that our

companies are as prepared as possible to reach the next level o growth. Companies that have

received signifcant unding through these and related programs to date include:

nAtreo Medical (CPRGlove) (medical devices)

nAdjuvent Inormatics Inc. (medical sotware)

nVineera or Lie (wine/agri-ood)

nBeeBiomedical (medical products)

nCenturion Biouels (biouel)

The growth achievements o these companies are big wins or the GHBN, and the network

looks orward to providing urther value through the addition o an Experts-in-Residence

program beginning in 2009.

...network for change


8/16

To capture the lie sciences

knowledge were generating

in the Golden Horseshoe,

we need the special

purpose space created by

an expanded incubator/

accelerator, to avoid the

knowledge and its potential

or commercialization going

elsewhere in the world.

By creating an important

interace o collaboration

with McMaster and the City

o Hamilton, the GHBN

is playing an important

acilitation role in ensuring

the required physical

inrastructure is in place.

Nick Markettos

Director, Strategic Partnerships and McMasterInnovation Park Liaison, McMaster Universityand Vice-President o Business Development,Board o Directors, Golden HorseshoeBiosciences Network (GHBN)

Facilitating new business support infrastructure

Strengthening eisting incbatr space

Upon inception o the GHBN in 2005, business incubator acilities in the Golden

Horseshoe were extremely limited. Recognizing a growing entrepreneurial appetite, the

commercialization potential o various research initiatives, and the value o co-location

or convergence o ideas and technologies, the GHBN played a lead role in ortiying

the McMaster Bioscience Incubation Centre (MBIC) in the Michael G. DeGroote Centreor Learning and Discovery, where the network is currently housed. MBIC provides

entrepreneurial researchers and start-up companies in the lie sciences sector with

resources to develop commercially successul products and services. Resources include

laboratories, scientic equipment and research requirements as well as business

mentoring and support services. In addition, MBIC oers shared administrative acilities

and oce equipment, executive meeting space, business advice and reerral services,

networking opportunities, and programs or o-site clients.

Creating capacity t absrb erfw

Further to MBIC, a need was also identied or expanded physical inrastructure to

accommodate the divergent needs o the broader biotech community. As a result, the

GHBN took on a catalyst role in developing the Bioscience Incubator/Accelerator atthe McMaster Innovation Park (MIP) delivering the business plan in association with

McMaster University and McMaster Innovation Park in 2007. Government unding is

now being pursued with groundbreaking or the proposed 80,000 sq t acility targeted

or 2009. The proposed acility oers entrepreneurs the most comprehensive convergence/

synergy centre opportunities in the region. As such, the GHBN plans to relocate to the

acility within three years to better serve the needs o clients and to most eectively

expand its own oering o events and workshops applicable across bio-related elds.

Creating new business opportunities

Fnding r clinical trials

Creating low cost access to clinical trials or SMEs has been a key priority or the GHBN

rom the outset in order to advance the commercialization potential particularly in

emerging sectors including medical devices. In partnership with The Health Technology

Exchange (HTX), Hamilton Health Sciences Centre and McMaster University, the GHBN

has helped secure over $300K or medical device clinical trials to take place between

2008 and 2010. The rst companies to be unded include:

nAtreoMedical Inc. (CPRGlove)

nTakeControl Cosmedix

nGolden Horseshoe Lie Sciences Inc. (ormerly Venowave Inc.)Bienergy adancement initiatie

In partnership with Vineland Research and Innovation Centre, the GHBN is playing a

acilitation role in establishing an energy-ocused demonstration initiative to benet

the wine, horticulture and agriculture industries in Niagara, as well as new economic

development and training opportunities. The project is in the ormative phases with

next steps including an RFP to secure a consultant to manage execution o the

demonstration project.


9/16


10/16

Ater eight years o research

and working with patients,

we have a ull-scale research

and development program

underway thanks in large

part to the mentorship and

connections provided through

the GHBN. Their assistance

in deciphering government

programs and connecting me to

the right people within the right

organizations at every stage

along the way has taken the

guesswork out o how to grow

my business. I look orward to a

continuing relationship with the

GHBN and highly value their

assistance to date.

Brandy Gowling,CEO / FounderTakeControl Cosmedix Inc.

nAtre Medical Inc., a medical devices company responsible or CPRGloveTM, a portable,

inexpensive, and adaptive device designed to greatly improve the success rate o cardio-

pulmonary resuscitation (CPR), and useul in CPR emergencies as well as training/testing

scenarios. A business mentor rom the companys early days, the GHBN has been

instrumental in helping Atreo:

- Develop its business plan

- Prepare or investor presentations

- Facilitate a clinical trial

- Secure a combined 775K in unding rom Ontario Centres o Excellence (OCE) the Investment

Accelerator Fund, and the GHBN/HTX/HHS/McMaster University Venture Funding Pilot

GHBN has been providing support and guidance to Atreo rom the very

beginning. They worked with us to develop our frst business plan and

investor pitch presentation, then helped us connect with the right people

and organizations to take us to the next level, including fnancing and

participation in the new clinical trials program GHBN is running in

partnership with HTX, McMaster University and Hamilton Health Sciences.

GHBN has provided all o this to us, and has asked nothing in return. It is

this altruistic spirit that sets GHBN ar apart rom other organizations.

Sarah Smith, B.Eng,COO, Atreo Medical Inc.

nBee Bimedical Inc., a small biopharmaceutical company, is involved in the manuacturing

o anti-viral, anti-infammatory topical skin therapies based on the bioactive compounds o

honey and propolis. The GHBN is helping the company to:

- Become investor-ready

- Identiy new nancial resources

- Access consulting services through the Business Mentorship and Entrepreneurship

Program (BMEP) oered through the Industrial Research Assistance Program o the

National Research Council (NRC-IRAP)

- Facilitate a clinical trial

- Gain contacts at the Agriculture Council o Canada and Ontario Centres o Excellence (OCE)

Funding results to date total almost $400K in development research.

Since I became an active client o the GHBN, Darlene Homonko has

taken her role as a navigator or my small company very seriously. She

introduced me to the bioscience business world, acilitating networking

with several crucial companies and scientists that could help my company

grow by accelerating research and commercialization o Bee-Biomedical

products. The unding Ive received has been instrumental to advancements

in my research on Canadian honey as an antibacterial agent, and a

commercial product is near. Katrina Brudzynski, Ph.D,Scientist, Bee-Biomedicals Inc. Adjunct Proessor, Brock UniversitynTakeCntrl Csmedi Inc., a medical devices company ocused on silicone-based

camoufage or disgurations caused by accidents, burns, skin cancer etc. A key relationship

acilitator or the company, the GHBN helped TakeControl to navigate through municipal

and provincial unding programs, resulting in:

- An R&D program with McMaster University and Ontario Centres o Excellence (OCE)

unding o $15K under the Interact Program

- $2500 rom the Industrial Research Assistance Program o the

National Research Council (NRC-IRAP)

- A clinical trial

- Clinic space allocation in the Hamilton Hospitals Assessment Centre,

under the umbrella o the Hamilton Health Sciences Corporation


11/16

F a s t F a C t sNumber of employees at GHBN: 4

Bioscience companies in theGolden Horseshoe: 175

Companies weve worked with: 32

Entrepreneurs weve worked with:

Clinical trials were facilitating: 3

Partners we work with: 35

R&D programs weve helped

facilitate:12

Trade shows weve helpedclients attend: 6

Key provincial programs weve

helped companies access: 4

Key federal programs weve

helped companies access: 3

International research programs

weve helped facilitate: 2

Future incubator/accelerator squa

footage weve helped establish:80,000

Individuals engaged in youth

outreach activities: 653

Investor presentations weve

assisted with: 5

Events hosted annually: 22

Event participants annually: 1,493

Grabbing new hnrs

McMaster University inventors o the

CPR Glove Nilesh Patel (let) Corey

Centen and Sarah Smith (absent rom

photo). The custom-made glove, design

to assist in cardio-pulmonary resuscitat

eorts, won in the undergraduate cate

at the Collegiate Inventors Competitio

in Caliornia.

sourCes oF Funding For the rin

by thenumbers

number oF Companies assisted

investment Leveraged

Funding ($) sourCed For Companies


12/16

Knowing our clients

The GHBN stands out because they really understand their clients.Brad DeFoe,Manager/A, Commercialization Branch, Ontario Ministry o Research and Innovation

A 2005 survey o stakeholders and clients in the biomedical and medical space in the

Golden Horseshoe was the oundation or the GHBNs current database. The next survey

planned or 2009 will incorporate the convergent space around bio, providing greater

insight into regional business development opportunities. While the number o companies in

the database will increase, the approach will remain highly ocused and knowledgeable o

individual company needs, to ensure the right resources are in place to continue propelling

companies orward.

Partnership promotion

The GHBNs partnership-based approach has ensured highly productive and non-competitive

relationships with partners within and outside the region. Regionally, collaboration with

the City o Hamilton and McMaster University has resulted in the business plan or the

Bioscience Incubator/Accelerator at the McMaster Innovation Park (MIP). Within Ontario,

collaboration with other Regional Innovation Networks (RINs), related ourth pillar

organizations and industry associations has resulted in jointly coordinated events, such as:

nA speaker panel series with partners BioDiscovery Toronto, Western Greater Toronto

Area Convergence Centre (WGTACC), YORKbiotech, and the Institute o Electrical

Engineers (IEE)

nGovernment program inormation sessions in partnership with the Health Technology

Exchange (HTX) and MaRS Discovery District

Internationally, the GHBN is ocused on opening the doors to new markets and creating

reciprocal training opportunities, through:

nPrograms including the Ontario-Israel Industrial Collaborative Research Projects

nCluster-to-cluster initiatives with universities and research institutions in France,

China, Italy and Brazil

nAn ongoing partnership with Bualo Niagara Enterprise (BNE)

Over the last ew years, Bualo

Niagara has ormed a very

positive working relationship

with our regional counterparts

rom Southern Ontario, including

the GHBN. By working together,

we can assist one another in

developing our innovation and

lie sciences based economies;

leveraging regional strengths to

promote business growth and

strengthen the overall economic

capacity o the bi-national region.

David S. Tyler,Business Development ManagerLie Sciences, Bualo Niagara Enterprise (BNE)

networking, partnerin

formulafor success

0


13/16

Focusing on what were good at

As a RIN the role o GHBN is to connect companies to the services they need to grow,

which requires us to acquire an in-depth o understanding o the company and use

our industry experience, business acumen and program knowledge to dene the most

ecient route to the next stage o development and beyond. Were true acilitators

in this regard, being careul not to use our limited resources in a way that duplicates

the capacity o partners and potential partners. The result is a oundational culture o

innovation ocused on synergies; where previous communication

silos have been replaced by awareness o services, and

more and more companies have the opportunity to take

advantage o the supports available.

Communicating effectively

Starting out three years ago, it was dicult tocomprehend the eort required to get the word out

about bioscience commercialization capacity in the Golden

Horseshoe, and to keep the story current. Accompanying the ull-

time job o networking, event participation and speaking engagements,

the GHBN also assumed responsibility or:

nBuilding and maintaining a compelling website, www.ghbn.org

nProducing a robust quarterly newsletter, Bio-Matrix

nDeveloping original content or top industry publications including Biotechnology

Focus, Canadas leading news authority on the Canadian lie sciences industry

Tools that help build knowledge and knowledge fow are a critical parto a successul Regional Innovation Network (RIN). Feedback on the GHBNs

communication tools to date has been excellent, with audiences becoming increasingly

inormed about the level o bioscience innovation happening in the Golden Horseshoe.

Going orward, the GHBNs communication tools will be enhanced through new

initiatives to produce:

nMore original content to drive additional trac to the website www.ghbn.org

nOnline billboard space to promote communication among industry clients

nAn online social networking tool to signicantly expand the network in a

non-obtrusive way

Through investment in expanded communications, the GHBNs goal is to provide

clients with the ability to increasingly source and create the connections they

need on their own; eectively helping clients to help themselves.

collaborating

GHBN knows the companies

in the Golden Horseshoe,

and through the scientifc and

entrepreneurial background o

Executive Director Dr. Darlene

Homonko, the network is well

qualifed to assist the companies

in their plans or growth. Even

at the pre-export stage, GHBN

is an extremely strong advocate

committed to ensuring well-

established business plans

so companies can begin the

process o working with us to

become export ready.

Patricia CosgroveInternational Marketing Consultant,Ontario Exports Inc


14/16

eye on the futureMoving forwardAs the network moves orward, the GHBN will continue to ocus on the needs o

entrepreneurs to achieve business growth and commercialization. Top scientists will look

to the GHBN or eective promotion and assistance with commercialization o innovations.

Partner relationships will be enhanced as the network continues to grow. Increasingly the

GHBN will be known as the entity capable o both overcoming traditional silos between

academia, government and industry; and channeling the potential o regional innovation

into a sustainable, community-supported business model.

To be successul it will be important to ensure nancial resources are maintained in

accordance with the program and services oering. As more companies come into

the old, the GHBN also needs to grow with additional well-qualied sta. Possibleadjustments toward a membership model will enhance the breadth and depth o client

engagement, enabling:

nStronger industry linkages

nA sense o ownership among companies

nA clear value proposition or companies at each stage o growth

nOngoing program relevancy

nExpanded networking and promotional opportunities

Within bioscience, medical and assistive devices currently provide the greatest potential or

the region, with a relatively short return on investment timeline, and an excellent t with

academic, research and manuacturing strengths. As such bioscience commercializationwill remain the networks core ocus, though the convergent space accompanying the

new synergy centre will necessitate build-out to embrace innovation and entrepreneurism

more broadly.

According to creative class guru and University o Toronto Proessor Richard Florida,

the economic activity, number o patents, rate o growth and location o the Golden

Horseshoe make it a virtual shoe-in to be part o a major economic boom, although

ultimate success will be determined by broad-based cultural support o innovation.

The GHBNs role in achieving that success or the Golden Horseshoe is centred on active

promotion and partnership to identiy and access the knowledge and nancial resources

required by entrepreneurs.

The strength o the region is in its ability to be convergent. The GHBN looks orward to the

buzz created by a bustling new synergy centre as well as ongoing partnerships to support

creation o a prosperous knowledge-based environment in the Golden Horseshoe. There is

great potential here.

Brad DeFoe, Manager/A,Commercialization Branch,Ontario Ministry o Research and Innovation

By adopting an inclusive

innovation ocus, the

Golden Horseshoe has an

opportunity to become a

powerhouse in the province.

there is great potenti


15/16

aboutus

Board of DirectorsE xE Cu T I vE

Laren CddyCHAIR OF THE BOARDEXECUTIVE VICE-PRESIDENTi3 Innovus

Nick MarkettosVICE-PRESIDENT, BUSINESS DEVELOPMENTDIRECTOR, Strategic Partnerships andMcMaster Innovation Park LiaisonMcMaster University

Elaine HoldingSECRETARYDIRECTOR, Client Services and MarketingSB Partners

Robert KloetTREASURERCertifed Management AccountantKloet Management Services

Darlene HomonkoPhDEXECUTIVE DIRECTORGolden Horseshoe Biosciences Network

D I RE CT o RS

Dr. Ian BrindleASSOCIATE VICE-PRESIDENTResearch & International DevelopmentBrock University

Dr. John CaponeDEAN OF SCIENCEMcMaster University

Dr. Stephen CollinsASSOCIATE DEAN OF RESEARCHMcMaster University

John DavidsonDIRECTOR

Business Development CentreRegional Municipality o Halton

Dr. Mo ElbestawiVICE-PRESIDENTResearch & International AairsMcMaster University

Michael J. Evelegh PhDEXECUTIVE VICE-PRESIDENTClinical & Regulatory AairsPreMD Inc.

Neil EversonEXECUTIVE DIRECTOREconomic Development DepartmentCity o Hamilton

Yosef Haj-Ahmad PhDPRESIDENT / CEONorgen Biotek Corp.

Dr. Jack HirshPROFESSOR EMERITUS OF MEDICINEHenderson Research CentreHenderson General Hospital

Patty HoogendoornCHIEF FINANCIAL OFFICERAfnity Biologicals Inc.

Start McKeenSENIOR POLICY ADVISORMinistry o Research & Innovation (MRI)Government o Ontario

John PellerCEO/PRESIDENTAndrew Peller Limited

Dr. Ian RodgerVICE-PRESIDENT OF RESEARCH & ACADEMICSt. Josephs Healthcare Hamilton

Brian underdown PhDMANAGING DIRECTORTechnology InvestingLumira Capital

Dr. Salim YsfPROFESSOR OF MEDICINEMcMaster University

DIRECTORPopulation Health Research Institute

VP OF RESEARCH,CHIEF SCIENTIFIC OFFICERHamilton Health Sciences

The teamSupported by the Board o Directors, the GHBN team includes:

Dr. Darlene Hmnk, Executive Director: [email protected]

Alice Bradbry, Special Projects and Events Coordinator: [email protected]

Jstin Plicarpi, Research Analyst: [email protected]

Ana Paredes, Oce Administrator/Incubator Assistant: [email protected]

Dr. Darlene Homonko has been Executive Director o the GHBN since its inception in 2005.

Through previous roles, Dr. Homonko has more than fve years experience in lie sciences commercialization

including our-plus years in venture capital. She has been instrumental in the creation o commercial

value rom innovative research secured in Milestone Medica Corporations (MMC) portolio companies.

From 2002-2004, Dr. Homonko was Director o Operations and Business Development or MolecularTemplates Inc., an MMC company. In 2004-2005, Dr. Homonko was also an Industry Liaison Ofcer

at the University o Toronto Innovations Foundation where she ocused on identiying new spin-out

opportunities in the lie science and convergent medical technologies.

Dr. Homonko has a valued reputation in the commercialization o lie sciences innovations with specifc

experience in start-ups. As well, she has a strong background in intellectual property management,

technology evaluation and analyzing corporate research and development in commercial alliances or sound

business practice. Dr. Homonko holds a Ph.D., Neuroscience rom the University o Toronto, Institute o

Medical Sciences; a M.Sc., Kinesiology rom Dalhousie University; and a B.Sc., Physical Education, Health,

General Science rom the University o Rhode Island.

here

p a r t n e r sAdvanced Food and Materials Network(AFMNet)

AllerGen NCE for Allergy / ImmunologBioDiscovery Toronto

BioEnterprise

BitNet

Brock University

Buffalo Niagara Economic DevelopmenCorporation

Canadian Obesity Network (CON)

City of Hamilton

Department of Foreign Affairs andInternational Trade Canada (DFAIT)

Eastern Lake Ontario Regional Innovati

Network (ELORIN)

Golden Horseshoe Angel Network

Golden Horseshoe Venture Forum (GHV

Hamilton Health Sciences

Health Technology Exchange (Htx.ca)

MaRS Landing

MaRS Discovery District

McMaster University

Mohawk College

Niagara College

Niagara Regional Economic Developme

Corporation

Ontario Ministry of Agriculture, Food anRural Affairs (OMAFRA)

Ontario Agriculture and Food Technolog(OAFT)

Ontario Centre for EnvironmentalTechnology Advancement (OCETA)

Ontario Centres of Excellence (OCE)

Ontario Exports Inc.

Region of Halton

R.I.C Centre

Southwestern Ontario Bioproducts

Innovation Network (SOBIN)

St. Joseph Health Care (Hamilton)

The Biotechnology Initiative (TBI)

Toronto Angel Group (TAG)

Trillium Medical Technology Association

Venture Niagara

Waterloo Research and Technology ParAccelerator

YORKbiotech


16/16

gl h bcc nwk

mm uy,00 m s w

mh G. dG c f lg & dy r 0

H, on c ln Z


Documents

Golden Horseshoe Biosciences Network - Annual Report